HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

International Cancer Research Conference

March 24-26, 2025 | Singapore

March 24 -26, 2025 | Singapore

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a rapid-progressing hematologic malignancy characterized by the uncontrolled proliferation of immature myeloid cells. Current cancer research focuses on understanding the genetic and molecular basis of AML to develop targeted therapies. Advances in genomics have identified mutations in genes such as FLT3, NPM1, and DNMT3A, providing insights into disease pathogenesis and potential therapeutic targets. Novel treatments, including FLT3 inhibitors and immune-based therapies like monoclonal antibodies and CAR-T cells, are under investigation. Additionally, researchers are exploring the role of the bone marrow microenvironment in AML progression and resistance to therapy, aiming to improve patient outcomes through personalized medicine.

Committee Members
Speaker at Cancer Research Conferences - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at Cancer Conferences - Atif A Ahmed

Atif A Ahmed

University of Washington-Seattle Children’s Hospital, United States
Speaker at Cancer Research Conferences - Jianhua Luo

Jianhua Luo

University of Pittsburgh, United States
Cancer Research 2025 Speakers
Speaker at Cancer Conferences - Kaushala Prasad Mishra

Kaushala Prasad Mishra

Asian Association for Radiation Research (AARR), India
Speaker at Oncology Conferences - Mariola Wioletta Borowska

Mariola Wioletta Borowska

Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Speaker at Oncology Conferences - Ibrahim El Bayoumy

Ibrahim El Bayoumy

Tanta faculty of medicine, Kuwait
Speaker at Cancer Research Conferences - Andrea González Báez

Andrea González Báez

Autonomous University of Nuevo Leon, Mexico

Submit your abstract Today

Watsapp